Medindia
About ▼ Careers Internship MedBlog Contact us
English (US) ▼
Medindia
LOGIN REGISTER
Advertisement

Neuro Kinetics Is Company 'To Watch,' Says Top Defense Publication

Friday, February 5, 2010 Corporate News
Advertisement
Heralds "Critically Important" Research into Early Diagnosis of Combat Brain Injuries

John Buckman

Buckman Communications, for Neuro Kinetics, Inc.

+ 1 412-381-2900

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

Olon Continues its Growth Path and Announces a New Acquisition
MILAN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The acquisition plan involves a complete operational integration of Huvepharma Italia Srl and a plan to revive the production potential o...
Philips and Dutch Isala Hospital Renew Long-term Partnership Focused on Innovation and Affordable, Sustainable Healthcare
August 13, 2024 Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Isala hospital (Zwolle, The Netherlands) have renewe...
Philips to Repurchase Shares for up to EUR 125 million to Cover Long-term Incentive Plans
August 5, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase shares for an amount of up to EUR 125 million to cover c...
Philips Delivers Strong Order intake Growth in the Second quarter, Margin improvement and Sales growth; Reiterates full-year Outlook
July 29, 2024 Second-quarter highlights Group sales amounted to EUR 4.5 billion, with comparable sales growth of 2% Comparable order intake increased by 9% Income from op...
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that ...
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close